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Cells integrate nutrient sensing and metabolism
to coordinate proper cellular responses to a partic-
ular nutrient source. For example, glucose drives
a gene expression program characterized by acti-
vating genes involved in its metabolism, in part
by increasing glucose-derived histone acetyla-
tion. Here, we find that lipid-derived acetyl-CoA is
a major source of carbon for histone acetylation.
Using 13C-carbon tracing combined with acetyl-pro-
teomics, we show that up to 90% of acetylation on
certain histone lysines can be derived from fatty
acid carbon, even in the presence of excess glucose.
By repressing both glucose and glutamine meta-
bolism, fatty acidoxidation reprogramscellularmeta-
bolism, leading to increased lipid-derived acetyl-
CoA. Gene expression profiling of octanoate-treated
hepatocytes shows a pattern of upregulated lipid
metabolic genes, demonstrating a specific transcrip-
tional response to lipid. These studies expand the
landscape of nutrient sensing and uncover how lipids
and metabolism are integrated by epigenetic events
that control gene expression.
INTRODUCTION
Cells sense nutrient availability and integrate signals into proper
metabolic and cellular responses by several mechanisms. For
example, nutrients influence cellular processes by providing
substrates for post-translational modification of proteins, which
control enzymatic activity or affect the epigenome to alter gene
expression patterns (Gut and Verdin, 2013). In this way, nutrients
and their metabolites can directly influence a wide range of
cellular processes. Proper integration of these metabolites and
signals is crucial for health, as dysregulation of protein and his-
tone modifications are associated with several disease states,
such as neurodegenerative diseases and cancer (Kaelin and
McKnight, 2013).Cell Repo
This is an open access article under the CC BY-NThe amino acid methionine is required for synthesis of S-ad-
enosylmethionine, which is the universal donor of methyl groups
for histone or DNA methylation. Levels of methionine and methi-
onine uptake dictate levels of histone methylation in vitro, as well
as in animals and humans (Dann et al., 2015;Mentch et al., 2015).
Similarly, acetyl-CoA is the substrate for histone acetylation.
The acetyl moiety from acetyl-CoA is added to lysines on histone
proteins by histone/lysine acetyl-transferase (HAT/KAT) pro-
teins. In general, increases in histone acetylation are associated
with chromatin relaxation, allowing access for transcription fac-
tors and activation of gene expression.
In yeast, themajor source of acetyl-CoA for histone acetylation
is acetate, which produces acetyl-CoA via acetyl-CoA synthe-
tase enzymes Acs1p and Acs2p (Takahashi et al., 2006). In
higher organisms, glucose has been described as the carbon
source of acetyl-CoA for histone acetylation. Glucose-derived
carbon produces citrate in mitochondria, which crosses into
the nucleus where the nuclear isoform of the enzyme ATP-citrate
lyase (ACLY) cleaves citrate to produce acetyl-CoA for histone
acetylation (Wellen et al., 2009). The addition of glucose and
serum to cells after serum starvation leads to increased histone
acetylation with a corresponding induction of genes involved in
glucose metabolism in vitro (Wellen et al., 2009). These studies
demonstrate that cells have sophisticated epigenetic mecha-
nisms to sense and integrate nutrient signals for activation of
coordinated gene expression programs.
While the relationship between glucose and histone acetylation
is well-known, we questioned whether histone acetylation was
unique to glucose-derived carbon and a glucose metabolic gene
expression program. Recently, studies have shown relationships
between histone acetylation and metabolites other than glucose
(Donohoe et al., 2012; Gao et al., 2016), suggesting that multiple
sources of carbon might integrate into the epigenome. Because
lipids can be a major source of cellular acetyl-CoA, we set out to
test whether lipid carbon contributes to histone acetylation.
RESULTS
Lipids Induce Histone Hyperacetylation
To test whether lipids could influence histone acetylation, we
used an eight-carbon, saturated fatty acid called octanoate,rts 17, 1463–1472, November 1, 2016 ª 2016 The Author(s). 1463
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Octanoate Causes Histone Hyper-
acetylation
(A) Western blot of histone acetylation in AML12
cells treated for 24 hr with octanoate or PBS
added to complete media. Data is presented as
fold change relative to control, error bars are SDs
of triplicate samples. Data is representative of
experiments repeated at least five times.
(B) Western blot of acetylated histone H3K9 in
cell lysates from AML12 cells. Cells were serum-
starved overnight and then treated for 24 hr with
base DMEM media (deplete of glucose, gluta-
mine, or pyruvate; containing 10% FBS) alone
or in combination with glucose (25 mM), glutamine
(4 mM), or octanoate (2 mM). Graph shows the
mean signal intensity of duplicate experiments
relative to vehicle control ± SEM with representa-
tive western blot shown.
(C) Quantitative proteomic analysis of protein
acetylation in AML12 cells treated for 24 hr with
vehicle or 2 mM octanoate added to complete
media, performed in triplicate. The graph shows
log2 fold-change of acetylated peptides in octa-
noate- versus PBS-treated samples with an
adjusted p value (padjusted)% 0.05 (5% FDR).
(D) Pie chart representing the top 50 most hyper-
acetylated peptides upon octanoate treatment
with padjusted% 0.05.
(E) Illustration summarizing the top ten most
acetylated histone peptides upon octanoate
treatment that make up the core nucleosome are
labeled in red.
(F) Western blot of histone H3K9 acetylation
in AML12 cells treated with various fatty acids
(2 mM) for 6 hr; the graph displays the mean signal
intensity relative to control from three independent
experiments; ±SEM with representative western
blot shown.
(G) Western blot of histone acetylation in multiple
cell lines treated for 24 hr with 2 mM octanoate.
See also Figure S1 and Table S1.which is a readily oxidized lipid known to increase ketone
body production (McGarry and Foster, 1971). Long-chain fatty
acids (LCFAs) (e.g., palmitate) have multiple cellular fates,
including re-esterification, desaturation, elongation, or oxidation
(Currie et al., 2013). The oxidation of LCFAs is controlled primar-
ily via the enzyme carnitine palmitoyltransferase 1 (CPT1), which
is required for the transport of LCFAs across the mitochon-
drial membrane. In contrast, medium-chain fatty acids (6–12 car-
bons), such as octanoate, uniquely drive fatty acid oxidation by
diffusing across mitochondrial membranes and bypassing
CPT1, thereby leading to rapid oxidation to acetyl-CoA (McGarry
and Foster, 1974). Using octanoate to drive lipid oxidation in
immortalized hepatocytes (alpha mouse liver 12 [AML12]), we
found a striking, dose-dependent increase in histone acetylation,
represented by the robust and well-characterized histone 3
lysine 9 (H3K9) acetylation mark (Figure 1A).1464 Cell Reports 17, 1463–1472, November 1, 2016We then compared histone acetylation
after octanoate treatment to the other
major cellular fuel sources in the cell,namely glucose and glutamine. Cells were serum-starved over-
night, followed by treatment with various nutrients in the pres-
ence of serum for 24 hr, as was performed previously (Wellen
et al., 2009). Cells were treated with base DMEM (a medium
containing no glucose, glutamine, or pyruvate with 10% fetal
bovine serum [FBS] added) or with the addition of 25 mM
glucose, 4 mM glutamine, 2 mM octanoate, or a combination
of glucose and glutamine (complete media) with octanoate.
Following treatment, histone acetylation wasmeasured by west-
ern blotting for acetylated H3K9. Treatment with glucose alone,
but not glutamine alone, led to amodest increase in histone acet-
ylation (20% over glucose-free media, Figure 1B). Remark-
ably, the addition of octanoate, either alone or in the presence
of glucose and glutamine, led to a striking increase in histone
acetylation (Figure 1B). Interestingly, simultaneously starving
the cells of glucose and glutamine increased histone acetylation
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Figure 2. Lipid Carbon Directly Acetylates Histones
(A–D) Representative MS1 spectra from AML12 cells treated with vehicle (A) or [U-13C]octanoate (C) added to complete media, highlighting the isotope distri-
bution of histone H3 peptides acetylated on lysines 9 and 14 (z = 2). The same is shown for precursor ions (z = 3) detecting histone H4 acetylation on lysines 8, 12,
(legend continued on next page)
Cell Reports 17, 1463–1472, November 1, 2016 1465
over nutrient-rich media (Figure 1B), which also may be due to
oxidation of lipids. These results show that lipids can induce
histone acetylation and suggest that lipid-induced histone acet-
ylation may be a dominant mechanism over glucose-induced
histone acetylation in the setting of complete nutrients.
To determine the breadth of changes in protein acetyla-
tion upon octanoate treatment, as well as the specificity for
different histone lysines, we performed an unbiased, quantitative
tandem mass tag (TMT)-based mass spectrometry proteomic
analysis, as has been performed previously (Grimsrud et al.,
2012). In whole cell lysates of AML12 cells cultured in complete
media with octanoate, we identified 573 acetylated peptides,
among which histones were the most hyperacetylated class
of proteins (Figures 1C and 1D; Table S1, ProteomeXchange:
PXD005040). Additionally, we found the top ten most acetylated
histone peptides were on lysines on core histones H2A, H3, and
H4 (Figure 1E), demonstrating a broad scope of histone hyper-
acetylation upon octanoate treatment.
Next, we tested whether histone acetylation was specific to
octanoate or if other readily oxidized medium-chain fatty acids
could also induce histone hyperacetylation. Like octanoate (C8,
caprylic acid), other medium-chain fatty acids hexanoate (C6,
caproic acid), decanoate (C10, capric acid), and dodecanoate
(C12, lauric acid) induced significant increases in histone acety-
lation when added to complete media (Figure 1F). Remarkably,
these fatty acids lead to a rapid induction of histone hyperacety-
lation, where all lipids increased histone acetylation after only 6 hr
(Figure 1F). Additionally, when palmitate (C16) oxidation is acti-
vated, we see increased histone acetylation at physiological lipid
doses (Figure S1A). Thus, these data show that a range of
fatty acids induce histone hyperacetylation, suggesting that
increasing lipid oxidation generally increases histone acetylation.
HDAC Inhibition Cannot Explain Histone
Hyperacetylation by Lipids
The ketone body b-hydroxybutyrate (bOHB) is an end-product
of fatty acid metabolism and is a known histone deacety-
lase (HDAC) inhibitor (Shimazu et al., 2013). Thus, we consid-
ered whether ketones, a well-known fate of octanoate oxidation
(McGarry and Foster, 1974), could be inhibiting HDACs and
increasing histone acetylation. We found that treating AML12
cells with exogenous bOHB at concentrations mimicking endog-
enous ketone levels produced from octanoate (Figure S1B),
or up to 30-fold higher, showed no change in histone acetyla-
tion (Figure S1C). These data suggest that endogenous ketone
inhibition of HDACs cannot explain the increases in histone acet-
ylation. Further, we found an induction of histone acetylation in
octanoate-treated cells across a panel of non-ketogenic cell
lines, including a hepatocyte cell line derived from hepatocellular
carcinoma (HepG2), human embryonic kidney cells (HEK293T),
as well as two breast cancer cell lines (MCF7 and MDA-MB-and 16 in vehicle (B) and [U-13C]octanoate (D)-treated samples. Mass shifts to th
histone lysines.
(E and F) Relative enrichments of acetylated sites for histone H3 (E) and histone
lysine in a given peptide was found to bemodifiedwith a 13C2-acetyl group; double
with [U-13C]octanoate-derived carbon. Red lower-case lysines indicate acetylate
See also Figure S2 and Table S2.
1466 Cell Reports 17, 1463–1472, November 1, 2016231), demonstrating octanoate increases histone acetylation in
many different cell types in the absence of ketone production
(Figures 1G and S1D). Together, these data support the idea
that histone acetylation is not due to production of bOHB by
octanoate and subsequent HDAC inhibition.
Given that the short-chain fatty acid butyrate is a well-known
HDAC inhibitor (Candido et al., 1978), we considered whether
the medium-chain fatty acid octanoate could be directly inhib-
iting HDACs. We measured enzyme activity for a range of re-
combinant HDACs (HDAC1, 2, 3, 6, and 8) when incubated
with octanoate and then compared these to the values achieved
by the HDAC inhibitors butyrate, trichostatin A (TSA), and sub-
eranilohydroxamic acid (SAHA) (Figure S1E). Relative to these
well-known inhibitors, we found that octanoate was a poor
HDAC inhibitor, consistent with previous results (Chang et al.,
2013); therefore, HDAC inhibition is unlikely to account for octa-
noate-induced histone acetylation.
Lipid-Derived Carbon Directly Acetylates Histones
We then sought to definitively determine whether lipid-derived
carbon was acetylating histones by tracing [U-13C]octanoate-
derived carbon onto acetyl-lysine carbon on histones. AML12
cells were treated with vehicle control or [U-13C]octanoate
added to complete media for 24 hr, followed by mass spec-
trometry analyses of purified histones to measure 13C-enrich-
ment on acetylated lysines, similar to a previous approach
(Evertts et al., 2013). In cells treated with 13C-octanoate, we
found that numerous acetylated histone peptides displayed
striking mass shifts in MS1 spectra compared to vehicle control,
consistent with the incorporation of octanoate-derived carbon
directly onto histones (Figures 2A–2D). Representative MS1
spectra from peptides containing the doubly-acetylated
H3K9,K14 histone peptide (Figures 2A and 2C) or the triply-acet-
ylated H4K8,K12,K16 histone peptide (Figures 2B and 2D)
showed remarkable incorporation of 13C-acetyl from 13C-octa-
noate (Table S2). To quantify the extent of enrichment of 13C car-
bon on these peptides, we corrected the MS1 mass isotopomer
distributions for natural 13C-isotope abundance and found that
85%–90% of the acetyl carbon on these histone peptides was
derived from octanoate (Figures 2E and 2F), demonstrating
that the overwhelming majority of histone acetylation on these
peptides is from octanoate. Thus, these data show that lipid-
derived carbon is a bona fide source of carbon for histone acet-
ylation and can modify the epigenome.
Octanoate Is Preferentially Oxidized and Generates
Acetyl-CoA
We then considered the mechanism by which medium-chain
fatty acids might produce carbon for histone acetylation. To
measure how lipids influence the overall cellular metabolic state,
we first performed steady-state metabolite profiling usinge right indicate presence of [U-13C]octanoate-derived carbon at those specific
H4 (F) corrected for natural abundance ± SD. Single 13C-acetyl indicates one
or triple acetyl means that two or three lysines of a given peptide are acetylated
d lysines (regardless of 13C enrichment).
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Figure 3. Octanoate Reprograms Cellular Metabolism
(A–C) Organic acid levels measured by tandem mass spectrometry of AML12 cells treated in quadruplicate for 24 hr with 2 mM octanoate compared to vehicle
added to complete media. Data is fold-change over control, ±SEM 14C-labeled pyruvate (B) or glutamine (C) oxidation in AML12 cells treated with or without
octanoate in complete media for 24 hr prior to capture and measurement of 14CO2. Mean normalized data shown from three independent experiments ± SEM.
*p < 0.05, **p < 0.01 (Student’s t test).
(D) Volcano plot of protein phosphorylation changes measured by TMT-based quantitative mass spectrometry of whole cell AML12 lysates treated for 24 hr with
octanoate or vehicle added to complete media; fold-change on a log2 scale versus p value on a negative log10 scale. Phosphopeptides showing statically
significant (padjusted < 0.1) increases or decreases in abundance in response to octanoate treatment are colored red or blue, respectively. Phosphopeptides
identifying Pdha1 serine 232 phosphorylation residues are highlighted.
(E) 13C-labeling of TCA cycle intermediates in AML12 cells treated with [U-13C]glucose or [U-13C]glutamine in the presence or absence of unlabeled 2 mM
octanoate compared to [U-13C]octanoate labeling in the presence of unlabeled glucose and glutamine.
(legend continued on next page)
Cell Reports 17, 1463–1472, November 1, 2016 1467
targetedmass spectrometry of acyl-carnitines, amino acids, and
organic acids (Figures 3A and S2). Octanoyl-carnitine and hexa-
noyl-carnitine were markedly elevated in octanoate-treated
cells, consistent with octanoate uptake and oxidation (Fig-
ure S2C). Furthermore, we observed specific increases in the
organic acids pyruvate, citrate, fumarate, andmalate (Figure 3A),
but no differences in amino acids (Figure S2A), suggesting that
the addition of octanoate to complete culture medium was
uniquely affecting the tricarboxylic acid (TCA) cycle.
To test this hypothesis, we interrogated TCA cycle meta-
bolism (Figures 3B and 3C). Increased pyruvate levels suggested
that pyruvate metabolism was altered in the presence of octa-
noate. Therefore, we measured the oxidation of [2-14C]pyruvate
to 14CO2 in octanoate-treated AML12 cells and found reduced
pyruvate oxidation (60% of control, Figure 3B), consistent
with a glucose-sparing effect known as the ‘‘Randle cycle’’ (Ran-
dle et al., 1963). Fatty acid oxidation inhibits glucose oxidation in
part by inhibiting pyruvate dehydrogenase (PDH) (Hue and
Taegtmeyer, 2009). Acetyl-CoA, reduced nicotinamide adenine
dinucleotide (NADH), and ATP generated by fatty acid oxidation
activate pyruvate dehydrogenase kinases and/or inhibit PDH
phosphatases, leading to increased phosphorylation and inhibi-
tion of PDH (Sugden and Holness, 2003). Accordingly, we found
serine 232 of PDH to have the greatest increase in phosphoryla-
tion in octanoate-treated AML12 cells compared to vehicle out of
267 phosphopeptides measured with significantly (Padjusted %
0.05) increased phosphorylation (Figure 3D; Table S1).
Reduced pyruvate metabolism, via genetic ablation of PDH or
the mitochondrial pyruvate carrier, can cause compensatory in-
creases in glutamine oxidation to supply anaplerotic substrates
for the TCA cycle (Rajagopalan et al., 2015; Yang et al., 2014).
Therefore, we predicted glutamine oxidation might be increased
in the presence of octanoate. However, when we measured
[U-14C]glutamine oxidation by 14CO2 capture, we found instead
that glutamine oxidation was also reduced upon octanoate treat-
ment (55% of control, Figure 3C), demonstrating that in addi-
tion to the known glucose-sparing effect in the setting of fatty
acid oxidation, octanoate induces a glutamine-sparing effect.
To further characterize how altered metabolism could lead
to lipid-derived histone acetylation, we determined the relative
contribution of three major fuel sources (glucose, glutamine,
and octanoate) to global metabolite pools using uniformly
labeled 13C-stable isotope tracers in AML12 cells treated with
octanoate. We found that under normal media conditions,
glucose and glutamine are the major fuel sources contributing
to the TCA cycle, approaching 80% of 13C-labeling for most
TCA cycle intermediates (Figure 3E). However, adding octanoate
to complete culture medium diminished the relative contribu-
tions of glucose and glutamine to TCA cycle intermediates,
which were replaced by octanoate-derived carbons (Figure 3E).(F and G) Mass isotopomer distribution (MID) of citrate from [U-13C]glucose (F) or
Error bars represent ± SD.
(H) Citrate MID from [U-13C]octanoate in the presence of unlabeled glucose and
(I) Acetate levels in media collected from AML12 cells with [U-13C]-labeled subst
(J) Acetyl-CoA labeling pattern from AML12 cells treated with [U-13C]-labeled su
media. Error bars represent ± SD.
(K) Model showing the metabolic fates of 13C-octanoate, -glucose or -glutamine
1468 Cell Reports 17, 1463–1472, November 1, 2016Further testing TCA cycle function, we traced carbon into the
TCA cycle by examining the isotope labeling pattern of citrate—
a central TCA cycle metabolite that can be produced from
glucose, glutamine, and fatty acids. From [U-13C]glucose, we
found the predominantly labeled isotopomer of citrate was
M+2, indicating pyruvate passed through PDH to form acetyl-
CoA and condensed with unlabeled four-carbon oxaloacetate
to form citrate (Figure 3F). However, when cells were given octa-
noate in the presence of [U-13C]glucose, M+2 citrate decreased
by more than 60% compared to control samples (Figure 3F).
Furthermore,M+4andM+5 isotopomers,which represent further
turns of glucose carbon in the TCA cycle, were almost undetect-
able upon octanoate treatment (Figure 3F), consistent with PDH
inhibition, and reduced contribution of glucose to the TCA cycle.
Consistent with lower glutamine oxidation (Figure 3C),
we observed a decrease in the M+4 citrate isotopomer from
[U-13C]glutamine in the presence of octanoate (Figure 3G).
Additionally, we observed increased unlabeled citrate (M+0),
indicating reduced glutamine anaplerosis into the TCA cycle
(Figure 3G). Importantly, we found that reductive glutamine
metabolism, which produces M+5 citrate, was also reduced in
the setting of octanoate, showing an overall inhibition of gluta-
mine flux into the TCA cycle.
When we monitored the fate of octanoate carbon in complete
media, nearly 90% of the total citrate pool contained at least
one carbon labeled from [U-13C]octanoate (Figure 3H). Impor-
tantly, octanoate treatment resulted in labeled citrate iso-
topomers M+4–M+6, which requires octanoate-derived carbons
to traverse multiple turns of the TCA cycle. Together, these
isotope tracing data show that octanoate becomes the predom-
inant fuel source in the cell over both glucose and glutamine.
Because citrate was heavily labeled by octanoate carbon,
we predicted the source of this carbon was from mitochondrial
acetyl-CoA generated by octanoate oxidation. However, octa-
noate is also oxidized to acetyl-CoA in peroxisomes, generating
two to four equivalents of acetate, a source of acetyl-CoA for
histone acetylation (Kasumov et al., 2005). We found octa-
noate-treated cells excreted nearly 100 mM acetate after 24 hr
(Figure3I), supporting the idea thatperoxisomal octanoateoxida-
tion generates a significant amount of acetyl-CoA that is hydro-
lyzed to acetate for excretion. Finally, we directly tested the
contribution of octanoate to the total cellular acetyl-CoA pool
and found that 75% of the acetyl-CoA pool was octanoate-
derived after 24 hr (Figure 3J). Together, these studies show
that octanoate oxidation leads to metabolic reprogramming
whereby lipid carbon is preferentially oxidized over other fuel
sources resulting in octanoate-derived carbon labeling a signifi-
cant fraction of the acetyl-CoA pool (Figure 3K); in this way,
lipid-derived carbon becomes the dominant source of acetyl
carbon for histone acetylation.[U-13C]glutamine (G) in the presence or absence of unlabeled 2 mM octanoate.
glutamine. Error bars represent ± SD.
rates for 24 hr. Error bars represent ± SD.
bstrates; all data collected after 24 hr. All experiments were done in complete
.
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Figure 4. Octanoate Causes a Specific Lipid Metabolism Gene Expression Signature
Microarray gene expression analysis of AML12 cells treated with vehicle or with 1 mM, 2 mM, or 5 mM octanoate added to complete media for 24 hr.
(A) Heatmap of all genes identified with upregulated genes in red and downregulated genes in blue for the given doses of octanoate.
(B) Gene set enrichment analysis (GSEA) of microarray data comparing vehicle to 2 mM octanoate. Ranked by p value on a -log10 scale with upregulated
pathways in red and downregulated in blue.
(C) qPCR analysis of lipid metabolic genes and genes found to be upregulated with octanoate treatment in microarray dataset. Cells were treated with vehicle or
2 mM octanoate for 24 hr.
(legend continued on next page)
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Octanoate Activates a Specific Gene Expression
Program
To identify the physiological role of lipid-induced histone
acetylation, we measured global changes in gene expression.
Indeed, histone acetylation is a key regulator of gene tran-
scription by ‘‘opening’’ chromatin to allow transcriptional
regulators to bind to those regions of DNA and drive gene
expression. To identify the genes and pathways that were
responding to octanoate treatment, we performed a gene
microarray analysis of cells treated with increasing amounts
of octanoate (1 mM, 2 mM, 5 mM) compared to control (Fig-
ure 4A, GEO: GSE87156). Gene set enrichment analyses
revealed that ‘‘fatty acid metabolic process’’ was the most
highly upregulated process (Figure 4B), demonstrating a spe-
cific gene expression response to lipid exposure. We identified
several lipid metabolism and lipid handling genes upregulated
in the gene microarray and confirmed these by qPCR (Fig-
ure 4C; Table S3).
Interestingly, pathways involving retinoid X receptor (RXR)
activation, including liver X receptor (LXR)/RXR and farnesoid
X receptor (FXR)/RXR activation, were identified by pathway
analysis (Ingenuity) as activated upon octanoate treatment
(Figure S3). Among the genes that were most highly expressed
in response to octanoate were retinoid metabolism genes,
including transthyretin (Ttr) and retinal dehydrogenase (Aldh1a1),
which are responsible for transporting retinol into cells and
converting retinal to retinoic acid, respectively (Figure 4C). Reti-
noic acid activates the nuclear hormone receptors RAR (retinoic
acid receptor) and RXR, activation of which are known to in-
crease the expression of genes involved in lipid and retinoid
metabolism (Bonet et al., 2012). The action of retinoic acid is
potentiated by HDAC inhibition and subsequent histone acetyla-
tion (Minucci et al., 1997). Thus, our findings suggest that activa-
tion of RXR or its partners could contribute lipid-specific gene
expression from octanoate, which may be potentiated by octa-
noate-induced histone acetylation.
Importantly, octanoate did not cause an induction of glucose-
metabolizing genes (Figure 4D), which have previously been
shown to be induced via glucose-derived histone acetylation
(Wellen et al., 2009). These data further support the idea that
cells respond to specific nutrients by inducing the correspond-
ing metabolic genes. Additionally, we measured expression of
several octanoate-induced genes after increasing histone acet-
ylation via HDAC inhibition. While histone acetylation induced
by TSA leads to a unique gene expression signature (Van Lint
et al., 1996), it did not lead to the same gene expression pattern
as octanoate (Figure 4E), demonstrating that histone acetylation
alone does not lead to generic gene expression signatures.
Together, these data show that signals emanating from lipids
drive histone acetylation and a specific lipid metabolic gene
expression pattern, which is different than glucose-driven gene
expression patterns or generic histone acetylation gene expres-
sion patterns.(D) qPCR analysis of genes associated with glucose-induced histone acetylation
(E) qPCR data of AML12 cells treated with vehicle, 2 mM octanoate, or 20 nM TS
data are representative of repeated experiments each performed in triplicate ± S
See also Figure S3 and Table S3.
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In this study, we describe a mechanism by which fatty acids are
sensed and integrated into the epigenome. Using stable isotope
tracing, we found lipid-derived carbons are deposited onto
histone lysines, demonstrating that lipids are a bona fide source
of carbon for histone acetylation. This occurs via a coordinated
mechanism where lipid oxidation reprograms metabolism,
leading to the production of lipid-derived acetyl-CoA. We show
histone acetylation is co-incident with activation of a lipid-spe-
cific gene expression program, which is different than the pro-
gram activated by glucose or TSA-induced histone acetylation.
Together, these finding identify a system where metabolism,
epigenetics, and gene expression coordinate the appropriate
cellular response to a nutrient signal.
Emerging evidence shows that metabolism and histone acet-
ylation are inextricably linked. Glucose is a canonical example of
how nutrient-derived carbon integrates into the epigenome
by histone acetylation (Wellen et al., 2009). More recently, de
novo fatty acid synthesis and histone acetylation have been
shown to use the same pool of acetyl-CoA, where knockdown
of acetyl-CoA carboxylase (ACC1, a crucial enzyme in fatty
acid synthesis), leads to histone hyperacetylation (Galdieri
and Vancura, 2012). Our data further define the relationship be-
tween fatty acidmetabolism and histone acetylation. Acetyl-CoA
derived from lipid oxidation is the predominant contributor to the
global acetyl-CoA pool, which is reflected in increased acetate,
citrate, and histone acetylation.
Interestingly, when we tested the possibility that canonical
acetate or citrate handling enzymes might be mediating lipid-
induced histone acetylation, we found no role. We knocked
down Acyl-CoA synthetase short-chain family member 2
(Acss2) or Acly, which have been shown to be involved in
regulation of acetate or glucose-induced histone acetylation,
respectively, and found no reduction in histone acetylation with
octanoate (Figure S4A). In fact, we found that ACLY expression
was decreased with increasing doses of octanoate while ACSS2
expression increased in AML12 cells (Figures S4B and S4C).
ACLY is a crucial enzyme in fatty acid synthesis; because
fatty acid synthesis and fatty acid oxidation are reciprocal pro-
cesses, decreased ACLY expression would be expected during
lipid oxidation. These data suggest against a role for ACLY and
ACSS2 in lipid-induced histone acetylation in this system; how-
ever, it does not exclude the possibility that theymight play a role
in lipid-induced histone acetylation in other settings.
The absence of a known metabolic or enzymatic interme-
diate step mediating histone acetylation in our study suggests
that other processes could be involved. For example, various
acetyl-CoA producing enzymes could influence the acetyl-CoA
pool therefore histone acetylation. Acetyl-carnitine formed in
mitochondria can be a source of acetyl groups for histone acet-
ylation via transportation out of mitochondria by carnitine-acyl-
carnitine translocase (CAT) and converted back to acetyl-CoAin AML12 cells treated with 2 mM octanoate.
A alone or in combination for 24 hr in complete media. qPCR gene expression
D. All experiments were done in complete media.
in the nucleus via nuclear carnitine acetyltransferase (CrAT)
(Madiraju et al., 2009). This model could be important for trans-
porting fatty acid-derived acetyl-CoA from the mitochondria
to produce nuclear acetyl-CoA for histone acetylation (Taylor
et al., 2014). An alternate possibility is that the compartmen-
talization of acetyl-CoA is not as rigid as is thought. The levels
of labeling of octanoate carbon into acetyl-CoA were remarkably
consistent with labeling in histone acetylation, as well as key
metabolites synthesized from acetyl-CoA (i.e., citrate or acetate
formation), regardless of compartment. While more work is
required to identify which enzymes and metabolic intermediates
lie between lipids and acetyl-CoA and how they are transported
for histone acetylation, our findings show that the source of car-
bon for histone acetylation is dictated by the predominant
contributor to the global acetyl-CoA pool.
Overall, our data support a model where multiple sources of
acetyl-CoA can lead to histone acetylation, which then promotes
gene expression. However, if multiple sources of acetyl-CoA can
increase histone acetylation, then the specificity of gene expres-
sion is likely encoded by nutrient-specific transcription factors
or transcriptional co-regulators. Consistent with this model,
we identified RAR/RXR activation by octanoate, which could
mediate the lipid metabolism-specific gene expression program
observed. Future studies will determine how metabolic and
epigenetic processes work together to ensure the appropriate
cellular response.
Dysregulated epigenetic modifications are known to play
a role in several disease states (Portela and Esteller, 2010).
Targeting epigenetics and metabolism are aggressively being
pursued as independent strategies to treat a variety of
diseases (Arrowsmith et al., 2012). Our data suggest that
metabolism and epigenetic regulation are inextricably linked,
and efficacious strategies may emerge from better under-
standing the connections between metabolism and epigenetic
regulation.
EXPERIMENTAL PROCEDURES
Cell Culture
AML12mouse hepatocytes, 293T cells, and HepG2 cells were purchased from
ATCC. MDA-MB-231 and MCF7 cells were gifts from Donald McDonnell’s
laboratory. All cell lines were cultured in DMEM high glucose media (Sigma
Cat #5796) without sodium pyruvate and were supplemented with 10% FBS
(GIBCO). Cells were treated with the medium-chain fatty acids (Sigma) sodium
hexanoate (C6), sodium octanoate (C8), and sodium decanoate (C10) dis-
solved in PBS, and sodium dodecanoate (C12) dissolved in 10% ethanol in
PBS. PBS was used as the vehicle control in all experiments. In experiments
containing C12 (Figure 1F), all samples also contained final concentration of
0.1% ethanol added to the medium. Cells were counted using a Beckman
Coulter Countess cell counter using Trypan blue exclusion and seeded at
the indicated densities. All experiments were done in complete DMEM with
10% FBS (referred to as complete media) with fatty acids or vehicle supple-
mented, unless otherwise noted.
qPCR
Cells were treated with octanoate for 24 hr washed with PBS, lysed with
Bio-Rad Aurum RNA lysis buffer, and frozen at 80C. RNA was isolated
using the Bio-Rad Aurum RNA mini kit as per protocol (Cat #7326820).
cDNA was synthesized using the Bio-Rad iScript cDNA synthesis kit
and diluted 1:10 with nuclease-free water. qPCR reaction mix contained
2.5 ml 1:10 cDNA, 0.5 mM of 10 mM forward and reverse primer mix, 4 mLiTAQ Universal SYBR green Supermix (BioRad), and 1 mL RNase/DNase
free water. qPCR was run using a Viia 7 Real-Time PCR system (Applied
Biosystems).
Western Blotting
Cells were plated and allowed to adhere overnight and then treated the
next day for the indicated times. Cells were collected prior to confluency,
washed with PBS, and lysed in radio immunoprecipitation assay (RIPA) buffer
including protease and/or phosphatase inhibitors. Lysis buffer contained
either tablet protease and phosphatase inhibitors (Roche), or Halt protease
and phosphatase inhibitor cocktail (ThermoFisher Scientific #78440). Cells
were blocked in 5% milk diluted in a mixture of Tris-buffered saline and
Polysorbate 20 (TBST; containing 0.1% tween) for at least 1 hr at room tem-
perature or overnight at 4C with rocking and then washed with TBST. Mem-
branes were incubated in primary antibody either overnight at 4C or at room
temperature for 1–2 hr with rocking. Primary antibodies were all purchased
from Cell Signaling Technologies and used at a concentration of 1:1,000.
Blots were washed with TBST and then incubated for 1 hr with rocking in
Li-Cor secondary antibodies used at a concentration of 1:10,000 in TBST.
Western blots were developed using a Li-Cor Odyssey CLx. Blots were
quantified using the Li-Cor software. Histone blots were performed with the
acetyl-histone antibody blot and total histone antibody probed on duplicate
blots run concurrently.
Statistical Analysis
All statistics performed were two-way Student’s t-tests with significance being
defined as p % 0.05. Statistics for the proteomics and microarray data are
outlined in the Supplemental Experimental Procedures.
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The accession numbers for the gene microarray and proteomic data re-
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